ACE2/Ang-(1–7) signaling and vascular remodeling

The renin-angiotensin system (RAS) regulates vascular tone and plays a critical role in vascular remodeling, which is the result of a complex interplay of alterations in vascular tone and structure. Inhibition of the RAS has led to important pharmacological tools to prevent and treat vascular diseases such as hypertension, diabetic vasculopathy and atherosclerosis. Angiotensin converting enzyme 2 (ACE2) was recently identified as a multifunctional monocarboxypeptidase responsible for the conversion of angiotensin (Ang) II to Ang-(1–7). The ACE2/Ang-(1–7) signaling has been shown to prevent cellular proliferation, pathological hypertrophy, oxidative stress and vascular fibrosis. Thus, the ACE2/Ang-(1–7) signaling is deemed to be beneficial to the cardiovascular system as a negative regulator of the RAS. The addition of the ACE2/Ang-(1–7) signaling to the complexities of the RAS may lead to the development of novel therapeutics for the treatment of hypertension and other vascular diseases. The present review considers recent findings regarding the ACE2/Ang-(1–7) signaling and focuses on its regulatory roles in processes related to proliferation, inflammation, vascular fibrosis and remodeling, providing proof of principle for the potential use of ACE2 as a novel therapy for vascular disorders related to vascular remodeling.     

Aldosterone signaling through transient receptor potential melastatin 7 cation channel (TRPM7) and its α-kinase domain

We demonstrated a role for the Mg^2 + transporter TRPM7, a bifunctional protein with channel and α-kinase domains, in aldosterone signaling. Molecular mechanisms underlying this are elusive. Here we investigated the function of TRPM7 and its α-kinase domain on Mg^2 + and pro-inflammatory signaling by aldosterone. Kidney cells (HEK-293) expressing wild-type human TRPM7 (WThTRPM7) or constructs in which the α-kinase domain was deleted (ΔKinase) or rendered inactive with a point mutation in the ATP binding site of the α-kinase domain (K1648R) were studied. Aldosterone rapidly increased [Mg^2 +]_i and stimulated NADPH oxidase-derived generation of reactive oxygen species (ROS) in WT hTRPM7 and TRPM7 kinase dead mutant cells. Translocation of annexin-1 and calpain-II and spectrin cleavage (calpain target) were increased by aldosterone in WT hTRPM7 cells but not in α-kinase-deficient cells. Aldosterone stimulated phosphorylation of MAP kinases and increased expression of pro-inflammatory mediators ICAM-1, Cox-2 and PAI-1 in Δkinase and K1648R cells, effects that were inhibited by eplerenone (mineralocorticoid receptor (MR) blocker). 2-APB, a TRPM7 channel inhibitor, abrogated aldosterone-induced Mg^2 + responses in WT hTRPM7 and mutant cells. In 2-APB-treated ΔKinase and K1648R cells, aldosterone-stimulated inflammatory responses were unchanged. These data indicate that aldosterone stimulates Mg^2 + influx and ROS production in a TRPM7-sensitive, kinase-insensitive manner, whereas activation of annexin-1 requires the TRPM7 kinase domain. Moreover TRPM7 α-kinase modulates inflammatory signaling by aldosterone in a TRPM7 channel/Mg^2 +-independent manner. Our findings identify novel mechanisms for non-genomic actions of aldosterone involving differential signaling through MR-activated TRPM7 channel and α-kinase.     

Let-7b contributes to hepatocellular cancer progression through Wnt/β-catenin signaling

Elevated evidences show that microRNAs (miRNAs) play vital roles in tumor progression regulation. However, the functional role of let-7b in hepatocellular carcinoma (HCC) is still largely unknown. In this study, we try to investigate the biological activity of let-7b in human HCC cells and try to find the potential regulatory signaling pathway. Our results indicate that let- 7b was remarkably down-regulated in human HCC tissues by qRT-PCR. In addition, let-7b overexpression decreased the expression of β-catenin and c-Myc, while upregulated E-cadherin expression in HCC cells which was verified by quantitative real-time PCR (qRT-PCR) and western blotting. Furthermore, Wnt/β-catenin was involved in let-7b biological activity which was revealed by luciferase assay. Moreover, Wnt/β-catenin signaling inhibitor blocks HCC cell proliferation which is as the same pattern as let-7b overexpression inhibits in HCC cells proliferation. In conclusion, down-regulated let-7b promotes HCC cell proliferation through Wnt/β-catenin signaling in HCC cells. These results suggested that appropriate manipulation of let-7b might be a new treatment of human HCC in the future.     

HSCARG downregulates NF-κB signaling by interacting with USP7 and inhibiting NEMO ubiquitination

Nuclear factor κB (NF-κB) signaling is a central pathway that participates in a variety of key processes, including immunity, inflammation, cell growth and differentiation. The activity of NF-κB is strictly regulated by a cluster of proteins, and modifications of these proteins either promote or suppress signal transduction at various steps. Here we demonstrated that HSCARG suppresses TNFα-stimulated NF-κB signaling under physiological conditions. We elucidated the detailed mechanism through which HSCARG inhibits NF-κB activation. HSCARG interacts with NEMO and suppresses polyubiquitination of NEMO by interacting with the deubiquitinase USP7. HSACRG attenuates its inhibitory effect on NEMO ubiquitination in USP7 knockdown cells, and inhibition of NEMO polyubiquitination by USP7 is impaired in HSCARG^−/− cells as well. Moreover, we demonstrated that USP7 is a negative regulator of TNFα-stimulated NF-κB activity. Altogether, our data indicate that HSCARG and USP7 function in concert in inhibiting polyubiquination of NEMO, thus inhibiting NF-κB activity.     

let-7 microRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor α signaling in breast cancer

MicroRNAs (miRNAs) play an important regulatory role in breast tumorigenesis. Previously, we found that let-7 miRNAs were downregulated significantly in formalin-fixed paraffin-embedded (FFPE) breast cancer tissues. In this study, we further found that endogenous levels of let-7b and let-7i miRNAs are inversely correlated with levels of estrogen receptor (ER)-a36, a new variant of ER-α66, in the FFPE tissue set. Bioinformatic analysis suggested that ER-α36 may be another target of let-7 miRNAs. To test this hypothesis, cotransfection of let-7 mimics or inhibitors together with full-length or a fragment of ER-α36 3'UTR luciferase construct was performed, and we found that let-7b and let-7i mimics suppressed the activity of reporter gene significantly, which was enhanced remarkably by let-7b and let-7i inhibitors. Both mRNA and protein expression of ER-α36 were inhibited by let-7 mimics and enhanced by let-7 inhibitors. Furthermore, ER-α36 mediated nongenomic MAPK and Akt pathways were weakened by let-7b and let-7i mimics in triple negative breast cancer cell line MDA-MB-231. The reverse correlation between let-7 miRNAs and ER-α36 also exists in Tamoxifen (Tam)-resistant MCF7 cell line. Transfection of let-7 mimics to Tam-resistant MCF7 cells downregulated ER-α36 expression and enhanced the sensitivity of MCF7 cells to Tam in estrogen-free medium, which could be restored by overexpression of ER-α36 constructs without 3'UTR. Our results suggested a novel regulatory mechanism of let-7 miRNAs on ER-α36 mediated nongenomic estrogen signal pathways and Tam resistance.     

All signaling is local?

The mechanism of signal transmission following ligand stimulation of receptor tyrosine kinases in living cells is poorly understood. Recent studies have visualized the spatio-temporal pattern of EGF signaling, indicating that receptor density is an important factor in the mechanism of lateral propagation of local EGF signaling.     

Engineering cell–cell signaling

1. Download : Download high-res image (160KB)
2. Download : Download full-size image

     

The Arabidopsis MAP kinase kinase 7: A crosstalk point between auxin signaling and defense responses?

Plant-pathogen interaction induces a complex host response that coordinates various signaling pathways through multiple signal molecules. Besides the well-documented signal molecules salicylic acid (SA), ethylene and jasmonic acid, auxin is emerging as an important player in this response. We recently characterized an Arabidopsis activation-tagged mutant, bud1, in which the expression of the MAP kinase kinase 7 (AtMKK7) gene is increased. The bud1 mutant plants accumulate elevated levels of SA and display constitutive pathogenesis-related (PR) gene expression and enhanced resistance to pathogens. Additionally, increased expression of AtMKK7 in the bud1 mutant causes deficiency in polar auxin transport, indicating that AtMKK7 negatively regulates auxin signaling. Based on these results, we hypothesized that AtMKK7 may serve as a crosstalk point between auxin signaling and defense responses. Here we show that increased expression of AtMKK7 in bud1 results in a significant reduction in free auxin (indole-3-acetic acid) levels in the mutant plants. We propose three possible mechanisms to explain how AtMKK7 coordinates the growth hormone auxin and the defense signal molecule SA in the bud1 mutant plants. We suggest that AtMKK7 may play a role in cell death and propose that AtMPK3 and AtMPK6 may function downstream of AtMKK7.Key words: Arabidopsis, MAP kinase kinase 7, auxin signaling, defense responses, crosstalkPathogen invasion of a plant induces multiple physiological changes at the site of infection, including the accumulation of reactive oxygen species, nitric oxide and salicylic acid (SA).^1–6 Jasmonic acid (JA) and ethylene (ET) are also produced in response to pathogen infection.^7–11 Numerous reports have documented that SA, JA and ET work synergistically or antagonistically to fine-tune plant defense responses, based on a multitude of environmental, host and pathogen genetic factors that vary depending on the pathogen-host combinations.^4,12The growth hormone auxin may also play an important role in plant defense responses. Many plant-pathogenic microorganisms have the ability to produce indole-3-acetic acid (IAA),¹³ which is important for the pathogenicity for some pathogens.^14–16 In the Arabidopsis-Xanthomonas campestris pv. campestris (Xcc) compatible interaction, Xcc triggers IAA synthesis in the host plants.17 Exogenous treatment of plants with the auxin analogs, NAA and 2,4-D, leads to disease susceptibility.¹⁸ A flagellin-derived-peptid e-induced microRNA (miRNA) was found to negatively regulate messenger RNAs for the F-box auxin receptors TIR1, AFB2 and AFB3, to repress auxin signaling, resulting in significantly enhanced host resistance.¹⁸ These results suggest that auxin likely functions as a virulence factor to suppress host defense.We previously identified an Arabidopsis activation-tagged mutant bud1 from a transgenic population generated by a sense/antisense RNA expression system.¹⁹ Further characterization indicated that bud1 is a semidominant mutant, in which the expression of the Arabidopsis MAP kinase kinase 7 (AtMKK7) gene is increased.²⁰ The increased expression of AtMKK7 in bud1 causes deficiency in auxin transport, whereas reducing mRNA levels of AtMKK7 by antisense RNA expression leads to enhancement of auxin transport, indicating that AtMKK7 negatively regulates polar auxin transport (PAT).²⁰ Recently, we have shown that the bud1 mutant plants accumulate elevated levels of SA and exhibit constitutive pathogenesis-related (PR) gene expression and enhanced resistance to both the bacterial pathogen Pseudomonas syringae pv. maculicola (Psm) ES4326 and the oomycete pathogen Hyaloperonospora parasitica Noco2.²¹ Reducing mRNA levels of AtMKK7 by antisense RNA expression not only compromises basal resistance but also blocks the induction of systemic acquired resistance (SAR), demonstrating that AtMKK7 is a positive regulator required for both basal resistance and SAR.²¹ Furthermore, we found that the free IAA levels in the bud1 mutant plants were significantly reduced, compared to those in wild-type plants (Fig. 1A). All these results taken together suggest that AtMKK7 may positively regulate SA signaling and negatively regulate auxin signaling.Open in a separate windowFigure 1(A) Free IAA levels in wild type (WT) and bud1 mutant plants. Thirty-day-old soil grown plants were used for free IAA measurement. (B) A schematic representation of three possible mechanisms through which MKK7 regulates host responses after pathogen invasion.Given that SA is a positive regulator of defense responses, whereas auxin is likely a negative regulator of defense responses, we propose three possible mechanisms through which AtMKK7 coordinates the growth hormone auxin and the defense signal molecule SA in the bud1 mutant plants (Fig. 1B): (1) AtMKK7 induces SA accumulation, which suppresses auxin signaling, leading to increased defense responses; (2) AtMKK7 independently induces SA accumulation and suppresses auxin signaling; (3) AtMKK7 suppresses auxin signaling, which relieves the repression of SA signaling by auxin, resulting in SA accumulation.We could test the hypotheses using different approaches. We can examine whether the expression of YUC1, YUC2, YUC4 and YUC6, genes that have been suggested to play essential roles in auxin biosynthesis,²² is altered in the bud1 mutant. We can also analyze the expression of YUC1, YUC2, YUC4 and YUC6, as well as the levels of free IAA in the double mutant bud1sid2 (sid2 is a SA deficient mutant) to test whether IAA biosynthesis is derepressed in the double mutant. Furthermore, polar auxin transport in the bud1sid2 plants should be determined. Finally, we can test whether exogenous application of auxin is able to suppress AtMKK7-induced constitutive defense responses in the bud1 mutant, including elevated levels of SA, constitutive PR gene expression and enhanced resistance to Psm ES4326 and H. parasitica Noco2.AtMKK7 belongs to the Group D of plant MAPKKs.²³ Functions of two other members of this group, LeMKK4 and NbMKK1, have been described.^24,25 LeMKK4 and NbMKK1 are orthologs of AtMKK7 in tomato and Nicotiana benthamiana, respectively. When overexpressed in leaves, wild-type LeMKK4 elicits cell death in both tomato and N. benthamiana.²⁴ Overexpression of wild-type NbMKK1 also causes cell death on N. benthamiana leaves.²⁵ We expected that overexpression of AtMKK7 would also result in cell death. However, neither increased expression of AtMKK7 in the bud1 mutant plants, nor overexpression of wild-type AtMKK7 from the dexamethasone-inducible promoter causes cell death.²¹ This is probably because the expression levels of AtMKK7 in these plants were below the threshold to induce cell death. Consistently, ectopic and constitutive expression of AtMKK7 driven by the cauliflower mosaic virus (CaMV) 35S promoter in wild-type plants leads to lethality of the transgenic plants.²⁰ Therefore, to characterize the function of AtMKK7 in cell death, transgenic plants expressing a constitutively active form of AtMKK7 (AtMKK7^S193A/S199D) from the dexamethasone-inducible promoter will be useful.What MAPK(s) acts downstream of AtMKK7? LeMKK4 directly phosphorylates LeMPK1, LeMPK2 and LeMPK3 in vitro, and activates LeMPK2 and LeMPK3 when expressed in tomato leaves,²⁴ whereas NbMKK1 activates NbSIPK when expressed in N. benthamiana leaves.²⁵ LeMPK2 and LeMPK3 are tomato orthologs of the well-studied tobacco proteins SIPK (salicylic acid-induced protein kinase) and WIPK (wound-induced protein kinase),^26,27 respectively. The Arabidopsis orthologs of SIPK and WIPK are AtMPK6 and AtMPK3, respectively. Based on previous in-gel kinase assay results,²¹ we predict that both AtMPK3 and AtMPK6 may function downstream of AtMKK7. Characterization of double mutants bud1atmpk3 and bud1atmpk6, as well as atmpk3 and atmpk6 mutant plants expressing the constitutively active form of AtMKK7 from the dexamethasone-inducible promoter will shed light on this question.     

Nodal induces apoptosis through activation of the ALK7 signaling pathway in pancreatic INS-1 β-cells

We demonstrated previously that the activation of ALK7 (activin receptor-like kinase-7), a member of the type I receptor serine/threonine kinases of the TGF-β superfamily, resulted in increased apoptosis and reduced proliferation through suppression of Akt signaling and the activation of Smad2-dependent signaling pathway in pancreatic β-cells. Here, we show that Nodal activates ALK7 signaling and regulates β-cell apoptosis. We detected Nodal expression in the clonal β-cell lines and rodent islet β-cells. Induction of β-cell apoptosis by treatment with high glucose, palmitate, or cytokines significantly increased Nodal expression in clonal INS-1 β-cells and isolated rat islets. The stimuli induced upregulation of Nodal expression levels were associated with elevation of ALK7 protein and enhanced phosphorylated Smad3 protein. Nodal treatment or overexpression of Nodal dose- or time-dependently increased active caspase-3 levels in INS-1 cells. Nodal-induced apoptosis was associated with decreased Akt phosphorylation and reduced expression level of X-linked inhibitor of apoptosis (XIAP). Remarkably, overexpression of XIAP or constitutively active Akt, or ablation of Smad2/3 activity partially blocked Nodal-induced apoptosis. Furthermore, siRNA-mediated ALK7 knockdown significantly attenuated Nodal-induced apoptosis of INS-1 cells. We suggest that Nodal-induced apoptosis in β-cells is mediated through ALK7 signaling involving the activation of Smad2/3-caspase-3 and the suppression of Akt and XIAP pathways and that Nodal may exert its biological effects on the modulation of β-cell survival and β-cell mass in an autocrine fashion.     

α7-Nicotinic acetylcholine receptor antagonist QND7 suppresses non-small cell lung cancer cell proliferation and migration via inhibition of Akt/mTOR signaling

Lung cancer, one of the most commonly found carcinoma type, has the highest mortality rate in cancer patients worldwide. Therapeutic interventions targeting to lung cancer become remaining the world significant challenge. Recently, the α7-nicotinic acetylcholine receptor (α7-nAChR) was reported to play an important role in the mechanism underlying lung cancer progression, being intriguing drug target for lung cancer therapy. Hence, the top four α7-nAChR antagonists (QND7, PPRD10, PPRD11 and PPRD12) among our previously developed ligands were proceeded to the in vitro anti-cancer evaluations in non-small cell lung cancer (NSCLC) cell lines (H460 and A549). In this study, we found that QND7 exhibited the highest cytotoxic effect and induced cell apoptosis in both cell lines at a level comparable to cisplatin, whereas the PPRD compounds showed much lower cytotoxicity. Low doses of QND7 and PPRD11 were able to suppress H460 and A549 cell proliferation, whereas PPRD10 and PPRD12 were considered ineffective. In an in vitro wound healing assay, QND7-treatment showed the greatest suppression of H460 and A549 cell migration. The variations in the anti-cancer activities of PPRD compounds might be, at least in part of, their non-selective antagonisms to serotonin receptor (5-HT3) and α4β2-nAChR. Further investigation revealed that QND7 was able to minimize protein kinase B/mammalian target of rapamycin (Akt/mTOR) activity, in correlating to its anti-cancer effects. These findings warrant QND7 for further preclinical evaluation and demonstrate the potential of α7-nAChR as cancer drug target.     

PKC�� take part in CCR7/NF-��B autocrine signaling loop in CCR7-positive squamous cell carcinoma of head and neck

Metastatic squamous cell carcinoma of head and neck (SCCHN) has been shown to express chemokine receptor 7 (CCR7). The role of nuclear factor-κB (NF-κB) in propagating an autocrine signaling loop in CCR7-positive SCCHN cells may provide a clinically useful biomarker of disease status and response to therapy. In this article, we hypothesized that PKCα might be involved in the CCR7/NF-κB autocrine signaling loop. Results showed that CCL19 induced the activation of PKCα, and the increased activity of PKCα was abolished by CCR7 mAb. PKCα inhibition with G?6976 led to significant reduction in the activation and nuclear translocation of NF-κB induced by CCL19. Immunohistochemical assay also showed that CCR7 and PKCα were highly expressed in SCCHN and correlated with each other, which was significantly related to lymph node metastasis and clinical stage. Taken together, PKCα is involved in the CCR7/NF-κB autocrine signaling loop.     

Deregulated ERK1/2 MAP kinase signaling promotes aneuploidy by a Fbxw7β-Aurora A pathway

Aneuploidy is a common feature of human solid tumors and is often associated with poor prognosis. There is growing evidence that oncogenic signaling pathways, which are universally dysregulated in cancer, contribute to the promotion of aneuploidy. However, the mechanisms connecting signaling pathways to the execution of mitosis and cytokinesis are not well understood. Here, we show that hyperactivation of the ERK1/2 MAP kinase pathway in epithelial cells impairs cytokinesis, leading to polyploidization and aneuploidy. Mechanistically, deregulated ERK1/2 signaling specifically downregulates expression of the F-box protein Fbxw7β, a substrate-binding subunit of the SCF^Fbxw7 ubiquitin ligase, resulting in the accumulation of the mitotic kinase Aurora A. Reduction of Aurora A levels by RNA interference or pharmacological inhibition of MEK1/2 reverts the defect in cytokinesis and decreases the frequency of abnormal cell divisions induced by oncogenic H-Ras^V12. Reciprocally, overexpression of Aurora A or silencing of Fbxw7β phenocopies the effect of H-Ras^V12 on cell division. In vivo, conditional activation of MEK2 in the mouse intestine lowers Fbxw7β expression, resulting in the accumulation of cells with enlarged nuclei. We propose that the ERK1/2/ Fbxw7β/Aurora A axis identified in this study contributes to genomic instability and tumor progression.     

α7 Nicotinic receptor activation reduces β-amyloid-induced apoptosis by inhibiting caspase-independent death through phosphatidylinositol 3-kinase signaling

The neurotoxicity of amyloid-β (Aβ) involves caspase-dependent and -independent programmed cell death. The latter is mediated by the nuclear translocation of the mitochondrial flavoprotein apoptosis inducing factor (AIF). Nicotine has been shown to decrease Aβ neurotoxicity via inhibition of caspase-dependent apoptosis, but it is unknown if its neuroprotection is mediated through caspase-independent pathways. In the present study, pre-treatment with nicotine in rat cortical neuronal culture markedly reduced Aβ(1-42) induced neuronal death. This effect was accompanied by a significant reduction of mitochondrial AIF release and its subsequent nuclear translocation as well as significant inhibition of cytochrome c release and caspase 3 activation. Pre-treatment with selective α7nicotinic acetylcholine receptor(nAChR) antagonist (methyllycaconitine), but not the α4 nAChR antagonist (dihydro-β-erythroidine), could prevent the neuroprotective effect of nicotine on AIF release/translocation, suggesting that nicotine inhibits the caspase-independent death pathway in a α7 nAChR-dependent fashion. Furthermore, the neuroprotective action of nicotine on AIF release/translocation was suppressed by LY294002, a phosphatidylinositol 3-kinase (PI3K) inhibitor. Pre-treatment with nicotine significantly restored Akt phosphorylation, an effector of PI3K, in Aβ(1-42) -treated neurons. These findings indicate that the α7 nAChR activation and PI3K/Akt transduction signaling contribute to the neuroprotective effects of nicotine against Aβ-induced cell death by modulating caspase-independent death pathways.